Iron Metabolism Disorders Unknown Status Phase Trials for Erythropoietin (DB00016)

IndicationStatusPhase
DBCOND0040533 (Iron Metabolism Disorders)Unknown StatusNot Available
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00687518Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy VolunteersBasic Science